89bio, Inc. (ETNB) Misses Q4 EPS by 1c

89bio, Inc. (NASDAQ: ETNB) reported Q4 EPS of ($0.50), $0.01 worse than the analyst estimate of ($0.49).

For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.

You May Also Be Interested In

• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
• SAP freezes hiring and travel to fund ’significant’ AI push - Reports
• Tesla Q2 deliveries crush forecasts at 480,126, erasing backlog concerns